Company intelligence / Profile preview

Lightfective

Ownership: Private
Development stage: Commercial

Overview

Lightfective has commercialized the ReBorn system, a non-invasive fat reduction device using patented Power LED technology. Clinical results highlight safe, effective, and consistent outcomes for body contouring with uniform heat delivery and minimal patient discomfort. The system is designed for professional use in medical aesthetics and is positioned as a new standard in light-based fat reduction treatments[1][2][3].

Therapeutic areas: OtherDermatology
Modalities: DeviceNon-pharmacological therapyEnergy-based therapy (Power LED)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Lightfective.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lightfective.

Explore the full profile